ArticleIntegrative cancer therapies
Combination of ShuangDan Capsule and Sorafenib Inhibits Tumor Growth and Angiogenesis in Hepatocellular Carcinoma Via PI3K/Akt/mTORC1 Pathway.
Wenbo Ding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
cites it